Indaptus Therapeutics, Inc. Earnings Per Share (Basic)
Indaptus Therapeutics, Inc. (INDP) reported Earnings Per Share (Basic) of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Indaptus Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.02.
- Indaptus Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.23.
- Indaptus Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$4.51.
- Indaptus Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$2.98.
- Indaptus Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$21.58.
- Indaptus Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$44.96.
- Indaptus Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.83.
- Indaptus Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.73.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.02 10-Q · filed 2026-08-13 | -$0.07 10-Q · filed 2026-08-13 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.23 10-Q · filed 2026-05-15 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.97 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$5.27 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$4.51 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$7.94 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$14.53 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$21.58 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | -$2.98 10-Q · filed 2025-11-12 | -$10.44 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$18.48 10-Q · filed 2025-11-12 | -$27.43 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$9.09 10-Q · filed 2026-08-13 | -$18.09 10-Q · filed 2026-08-13 | -$28.49 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$37.64 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$9.11 10-Q · filed 2026-05-15 | -$0.32 10-Q · filed 2025-05-14 | -$19.51 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$28.67 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$41.10 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2024-12-31 | -$10.59 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$19.73 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$32.51 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$44.96 10-K · filed 2026-03-17 | -$1.61 10-K · filed 2025-03-13 | |||
| 2024-09-30 | -$9.04 10-Q · filed 2025-11-12 | -$0.32 10-Q · filed 2024-11-12 | -$21.97 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$34.53 10-Q · filed 2025-11-12 | -$1.23 10-Q · filed 2024-11-12 | -$3.41 derived: net income ÷ weighted average shares · filed 2026-07-16 | ||
| 2024-06-30 | -$13.16 10-Q · filed 2025-08-13 | -$0.47 10-Q · filed 2024-08-12 | -$25.79 10-Q · filed 2025-08-13 | -$0.92 10-Q · filed 2024-08-12 | -$2.07 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$2.47 derived: net income ÷ weighted average shares · filed 2026-07-16 | ||
| 2024-03-31 | -$0.45 10-Q · filed 2025-05-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$1.78 derived: net income ÷ weighted average shares · filed 2026-07-16 | ||||
| 2023-12-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-07-16 | -$1.83 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$0.47 10-Q · filed 2024-11-12 | -$0.85 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.36 10-Q · filed 2024-11-12 | -$1.80 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-06-30 | -$0.39 10-Q · filed 2024-08-12 | -$0.89 10-Q · filed 2024-08-12 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.75 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-03-31 | -$0.51 10-Q · filed 2024-05-08 | -$0.95 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.83 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2022-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$1.73 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$0.42 10-Q · filed 2023-11-06 | -$0.88 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$1.29 10-Q · filed 2023-11-06 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-11-06 | ||||
| 2022-06-30 | -$0.46 10-Q · filed 2023-08-14 | -$0.87 10-Q · filed 2023-08-14 | -$1.26 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$1.90 derived: net income ÷ weighted average shares · filed 2023-11-06 | ||||
| 2022-03-31 | -$0.41 10-Q · filed 2023-05-11 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$1.44 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$1.85 derived: net income ÷ weighted average shares · filed 2023-11-06 | ||||
| 2021-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$1.06 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$1.48 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$1.89 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | -$0.81 10-Q · filed 2022-11-10 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.67 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.27 10-Q · filed 2022-08-08 | -$0.58 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | -$0.31 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |